New MOU pairs GlycanAge’s glycan-based biological age test with ExoEarth’s exosome platform, bringing inflammaging testing deeper into Japan.
Link as first comment.
#longevity #geroscience #glycanage #biologicalage #inflammaging
Link as first comment.
#longevity #geroscience #glycanage #biologicalage #inflammaging
September 11, 2026 at 1:14 PM
New MOU pairs GlycanAge’s glycan-based biological age test with ExoEarth’s exosome platform, bringing inflammaging testing deeper into Japan.
Link as first comment.
#longevity #geroscience #glycanage #biologicalage #inflammaging
Link as first comment.
#longevity #geroscience #glycanage #biologicalage #inflammaging
ExoEarthとGlycanAge社、糖鎖バイオマーカーを活用した提携を発表#東京都#港区#ExoEarth#ロンジェビティ#GlycanAge
ExoEarthとGlycanAge社が戦略的提携を結び、日本での糖鎖による生物学的年齢測定を広める計画を発表しました。
ExoEarthとGlycanAge社が戦略的提携を結び、日本での糖鎖による生物学的年齢測定を広める計画を発表しました。
ExoEarthとGlycanAge社、糖鎖バイオマーカーを活用した提携を発表
ExoEarthとGlycanAge社が戦略的提携を結び、日本での糖鎖による生物学的年齢測定を広める計画を発表しました。
news.3rd-in.co.jp
September 8, 2026 at 2:00 AM
ExoEarthとGlycanAge社、糖鎖バイオマーカーを活用した提携を発表#東京都#港区#ExoEarth#ロンジェビティ#GlycanAge
ExoEarthとGlycanAge社が戦略的提携を結び、日本での糖鎖による生物学的年齢測定を広める計画を発表しました。
ExoEarthとGlycanAge社が戦略的提携を結び、日本での糖鎖による生物学的年齢測定を広める計画を発表しました。
GlycanAge doesn't ask how old you are. It reads the sugar on your antibodies to tell you how fast you're aging.
https://yespress.io/glycanage?utm_source=bluesky&utm_medium=social via Yespress
https://yespress.io/glycanage?utm_source=bluesky&utm_medium=social via Yespress
yespress.io
September 1, 2026 at 1:31 PM
GlycanAge doesn't ask how old you are. It reads the sugar on your antibodies to tell you how fast you're aging.
https://yespress.io/glycanage?utm_source=bluesky&utm_medium=social via Yespress
https://yespress.io/glycanage?utm_source=bluesky&utm_medium=social via Yespress
GlycanAge dynamics and their relationship to SCORE2 risk change over six months: a secondary analysis of a randomized controlled trial
GlycanAge dynamics and their relationship to SCORE2 risk change over six months: a secondary analysis of a randomized controlled trial
chuckyscarnage.tech.blog
August 29, 2026 at 9:57 PM
GlycanAge dynamics and their relationship to SCORE2 risk change over six months: a secondary analysis of a randomized controlled trial
Nikolina Lauc turned her father's glycan research lab into GlycanAge, one of Europe's most-watched longevity startups.
Full story on https://yespress.io/nikolina-lauc?utm_source=bluesky&utm_medium=social
Full story on https://yespress.io/nikolina-lauc?utm_source=bluesky&utm_medium=social
Nikolina Lauc - The Sugar on the Antibody
yespress.io
August 11, 2026 at 9:31 PM
Nikolina Lauc turned her father's glycan research lab into GlycanAge, one of Europe's most-watched longevity startups.
Full story on https://yespress.io/nikolina-lauc?utm_source=bluesky&utm_medium=social
Full story on https://yespress.io/nikolina-lauc?utm_source=bluesky&utm_medium=social
За хората, които активно работят върху здравето си, ежегодното изследване осигурява дългосрочно проследяване на промените в биологичната възраст. GlycanAge е личен инструмент и ориентир, който показва на хората какво работи за тях и какво могат да коригират👇
nmgenomix.com/igg-glikozil...
nmgenomix.com/igg-glikozil...
IgG гликозилиране и възпалително стареене | GlycanAge
Научете как IgG гликозилирането отразява възпалителното стареене, състоянието на имунната система и биологичната възраст.
nmgenomix.com
July 30, 2026 at 10:06 AM
За хората, които активно работят върху здравето си, ежегодното изследване осигурява дългосрочно проследяване на промените в биологичната възраст. GlycanAge е личен инструмент и ориентир, който показва на хората какво работи за тях и какво могат да коригират👇
nmgenomix.com/igg-glikozil...
nmgenomix.com/igg-glikozil...
Нормалният CRP все още може да пропусне хронично възпаление. CRP и СУЕ не винаги отразяват нискостепенното възпаление, което може да се хронифицира❗Тестът #GlycanAge на цена от 599€ измерва маркери за дългосрочни промени в имунното стареене👉 nmgenomix.com/glycanage/
GlycanAge - НАЙ-ПРЕЦИЗНИЯТ ТЕСТ ЗА БИОЛОГИЧНА ВЪЗРАСТ
ЗАЯВИ ТЕСТ GlycanAge е иновативно изследване за биологична възраст, което оценява състоянието на имунната система чрез измерване нивата на хронично възпаление – ключов фактор за развитието на…
nmgenomix.com
June 22, 2026 at 10:34 AM
Нормалният CRP все още може да пропусне хронично възпаление. CRP и СУЕ не винаги отразяват нискостепенното възпаление, което може да се хронифицира❗Тестът #GlycanAge на цена от 599€ измерва маркери за дългосрочни промени в имунното стареене👉 nmgenomix.com/glycanage/
Кой е един от най-прецизните тестове за биологична възраст? Вижте тук 👇
nmgenomix.com/glycanage/
nmgenomix.com/glycanage/
June 11, 2026 at 11:26 AM
Кой е един от най-прецизните тестове за биологична възраст? Вижте тук 👇
nmgenomix.com/glycanage/
nmgenomix.com/glycanage/
A preprint from GlycanAge and the Buck Institute (Lauc et al., 2026), pooling IgG N-glycome data from 20,405 people across 42 studies, validates the IgG glycome as a predictor of all-cause mortality. And it is modifiable. (2/6)
May 20, 2026 at 12:21 PM
A preprint from GlycanAge and the Buck Institute (Lauc et al., 2026), pooling IgG N-glycome data from 20,405 people across 42 studies, validates the IgG glycome as a predictor of all-cause mortality. And it is modifiable. (2/6)
Unlocking the Future of Longevity: Glycans as Key Biomarkers in Aging and Health#USA#Seattle#Therapeutic_Plasma_Exchange#GlycanAge#Aging_Biomarkers
Unlocking the Future of Longevity: Glycans as Key Biomarkers in Aging and Health
Recent studies reveal that glycans can serve as reliable biomarkers for aging. Therapeutic plasma exchange offers the most significant reduction in biological age, pushing boundaries in longevity research.
third-news.com
May 19, 2026 at 2:44 PM
Unlocking the Future of Longevity: Glycans as Key Biomarkers in Aging and Health#USA#Seattle#Therapeutic_Plasma_Exchange#GlycanAge#Aging_Biomarkers
Latest Research Confirms Glycans as Aging Biomarkers with Therapeutic Plasma Exchange Benefits#USA#Seattle#Circulate_Health#GlycanAge#Aging_Biomarkers
Latest Research Confirms Glycans as Aging Biomarkers with Therapeutic Plasma Exchange Benefits
Recent research validates IgG glycans as key aging biomarkers. Therapeutic plasma exchange shows significant potential to reduce biological age effectively.
third-news.com
May 19, 2026 at 2:10 PM
Latest Research Confirms Glycans as Aging Biomarkers with Therapeutic Plasma Exchange Benefits#USA#Seattle#Circulate_Health#GlycanAge#Aging_Biomarkers
A landmark conference hosted by GlycanAge aims to turn 25 years of inflammaging research into practical tools for doctors and patients.
Link as first comment.
#longevity #geroscience #inflammaging #biomarkers #glycans
Link as first comment.
#longevity #geroscience #inflammaging #biomarkers #glycans
May 8, 2026 at 9:16 AM
A landmark conference hosted by GlycanAge aims to turn 25 years of inflammaging research into practical tools for doctors and patients.
Link as first comment.
#longevity #geroscience #inflammaging #biomarkers #glycans
Link as first comment.
#longevity #geroscience #inflammaging #biomarkers #glycans
Their terms and conditions:
“The Services are not intended to be used by the customer for any diagnostic purpose and are not a substitute for professional medical advice.”
“GlycanAge does not endorse, warrant or guarantee the effectiveness of… information that may be mentioned on our website. “
“The Services are not intended to be used by the customer for any diagnostic purpose and are not a substitute for professional medical advice.”
“GlycanAge does not endorse, warrant or guarantee the effectiveness of… information that may be mentioned on our website. “
May 2, 2026 at 9:52 AM
Their terms and conditions:
“The Services are not intended to be used by the customer for any diagnostic purpose and are not a substitute for professional medical advice.”
“GlycanAge does not endorse, warrant or guarantee the effectiveness of… information that may be mentioned on our website. “
“The Services are not intended to be used by the customer for any diagnostic purpose and are not a substitute for professional medical advice.”
“GlycanAge does not endorse, warrant or guarantee the effectiveness of… information that may be mentioned on our website. “
Inflammaging in Clinical Practice: GlycanAge’s New Data
Inflammaging in Clinical Practice: GlycanAge’s New Data
Inflammaging in Clinical Practice: Bringing the Science to Clinicians Two decades before longevity became a […]
The post Inflammaging in Clinical Practice: GlycanAge’s New Data appeared first on TheRecursive.com.
therecursive.com
March 30, 2026 at 3:10 PM
Inflammaging in Clinical Practice: GlycanAge’s New Data
Finland
IQM, ICEYE, Oura,, Nanoform Finland Oyj, Endomines Finland Oyj, Snowfox.AI
Greece
Blueground, Harbor Lab, Ferryhopper, InstaShop
Croatia
GlycanAge, Infobip, Moontop
Israel
monday,com, Finout, Quantum Machines, Scale AI
egal.space/blog/investm...
IQM, ICEYE, Oura,, Nanoform Finland Oyj, Endomines Finland Oyj, Snowfox.AI
Greece
Blueground, Harbor Lab, Ferryhopper, InstaShop
Croatia
GlycanAge, Infobip, Moontop
Israel
monday,com, Finout, Quantum Machines, Scale AI
egal.space/blog/investm...
investment opportunities Finland, Greece, Croatia, Israel
egal.space
January 18, 2026 at 12:42 AM
Finland
IQM, ICEYE, Oura,, Nanoform Finland Oyj, Endomines Finland Oyj, Snowfox.AI
Greece
Blueground, Harbor Lab, Ferryhopper, InstaShop
Croatia
GlycanAge, Infobip, Moontop
Israel
monday,com, Finout, Quantum Machines, Scale AI
egal.space/blog/investm...
IQM, ICEYE, Oura,, Nanoform Finland Oyj, Endomines Finland Oyj, Snowfox.AI
Greece
Blueground, Harbor Lab, Ferryhopper, InstaShop
Croatia
GlycanAge, Infobip, Moontop
Israel
monday,com, Finout, Quantum Machines, Scale AI
egal.space/blog/investm...
GlycanAge Secures €7.4M to Advance Ageing Tech
UK-based longevity startup GlycanAge recently raised €7.4 million, equivalent to $8.7 million, in fresh funding. This investment accelerates the clinical development of its innovative technology. Moreover, it expands access to glycan testing for…
UK-based longevity startup GlycanAge recently raised €7.4 million, equivalent to $8.7 million, in fresh funding. This investment accelerates the clinical development of its innovative technology. Moreover, it expands access to glycan testing for…
GlycanAge Secures €7.4M to Advance Ageing Tech
UK-based longevity startup GlycanAge recently raised €7.4 million, equivalent to $8.7 million, in fresh funding. This investment accelerates the clinical development of its innovative technology. Moreover, it expands access to glycan testing for clinicians worldwide. The company focuses on personalized, preventative healthcare. Investors see great potential in its approach to ageing. Funding Round Details Fifth Quarter Ventures led the funding round.
therealpreneur.com
December 30, 2025 at 5:00 PM
GlycanAge Secures €7.4M to Advance Ageing Tech
UK-based longevity startup GlycanAge recently raised €7.4 million, equivalent to $8.7 million, in fresh funding. This investment accelerates the clinical development of its innovative technology. Moreover, it expands access to glycan testing for…
UK-based longevity startup GlycanAge recently raised €7.4 million, equivalent to $8.7 million, in fresh funding. This investment accelerates the clinical development of its innovative technology. Moreover, it expands access to glycan testing for…
“UK-based, Croatian-founded biotech startup GlycanAge raises 7.4 mln euro” — SeeNews
#StartupNews #Startups #Biotech
#StartupNews #Startups #Biotech
December 23, 2025 at 8:54 AM
“UK-based, Croatian-founded biotech startup GlycanAge raises 7.4 mln euro” — SeeNews
#StartupNews #Startups #Biotech
#StartupNews #Startups #Biotech
GlycanAge Secures $8.7M to Pioneer Preventive Biotech
Modern healthcare excels at treating diseases. However, it struggles to detect risks early. Most hospital tests reveal existing problems. They rarely show how fast the body ages or if chronic inflammation builds quietly. This gap hinders…
Modern healthcare excels at treating diseases. However, it struggles to detect risks early. Most hospital tests reveal existing problems. They rarely show how fast the body ages or if chronic inflammation builds quietly. This gap hinders…
GlycanAge Secures $8.7M to Pioneer Preventive Biotech
Modern healthcare excels at treating diseases. However, it struggles to detect risks early. Most hospital tests reveal existing problems. They rarely show how fast the body ages or if chronic inflammation builds quietly. This gap hinders preventive care. Doctors lack tools to monitor lifestyle or treatment effects over time. London-based biotech startup GlycanAge aims to bridge this divide. GlycanAge recently raised $8.7 million in funding.
therealpreneur.com
December 21, 2025 at 1:00 PM
GlycanAge Secures $8.7M to Pioneer Preventive Biotech
Modern healthcare excels at treating diseases. However, it struggles to detect risks early. Most hospital tests reveal existing problems. They rarely show how fast the body ages or if chronic inflammation builds quietly. This gap hinders…
Modern healthcare excels at treating diseases. However, it struggles to detect risks early. Most hospital tests reveal existing problems. They rarely show how fast the body ages or if chronic inflammation builds quietly. This gap hinders…